Objective
to investigate the 2-year clinical outcomes of biodegradable âpolymer sirolimus stents (BP-SES) and durable-polymer everolimus-eluting stents (DP-EES) in patients with STEMI
Study
investigator-initiated, single-blind, multicentre randomised trial
Population
patients undergoing primary PCI for STEMI
Endpoints
target lesion failure as composite of cardiac death, target-vessel MI, and clinically indicated target-lesion revascularisation at 2 years
Conclusion
BP-SES was superior to DP-EES in patients with STEMI undergoing primary PCI at 2-year follow-up
Pilgrim et al. J Am Coll Cardiol Interv. 2021;14:639-48